Citadel Advisors »

Indaptus Therapeutics shares owned by Citadel Advisors

Quarter-by-quarter ownership of Indaptus Therapeutics (INDP) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Indaptus Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Indaptus Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Indaptus Therapeutics by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $71k 39k 1.82

More positions owned by Citadel Advisors

State Str Spdr S&p 500 Etf T Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
NVIDIA Corporation Call Option (NVDA)
Tesla Motors Call Option (TSLA)
Spdr Gold Tr Gold Shs Call Option (GLD)
Apple Call Option (AAPL)
Meta Platforms Cl A Call Option (META)
Microsoft Corporation Call Option (MSFT)
Amazon Call Option (AMZN)
Micron Technology Call Option (MU)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Netflix Call Option (NFLX)
Broadcom Call Option (AVGO)
Alphabet Cap Stk Cl C Call Option (GOOG)

View all positions for Citadel Advisors

Top funds holding Indaptus Therapeutics

Citadel Advisors
Geode Capital Management
Tower Research Capital
Morgan Stanley
SBI Securities

View all funds holding Indaptus Therapeutics